AdaptHealth Corp. (NASDAQ:AHCO) Receives $10.29 Average PT from Analysts

AdaptHealth Corp. (NASDAQ:AHCO) has been assigned a consensus recommendation of “Moderate Buy” from the nine analysts that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and seven have assigned a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $10.2857.

A number of research analysts recently weighed in on AHCO shares. Royal Bank Of Canada decreased their target price on shares of AdaptHealth from $15.00 to $8.00 and set an “outperform” rating for the company in a research report on Thursday, August 6th. Weiss Ratings reissued a “sell (d)” rating on shares of AdaptHealth in a research report on Wednesday. Jefferies Financial Group upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating and increased their price objective for the stock from $11.00 to $13.00 in a research note on Tuesday, July 21st. UBS Group reduced their price objective on shares of AdaptHealth from $14.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, August 6th. Finally, Robert W. Baird set a $10.00 price objective on AdaptHealth in a report on Wednesday, August 5th.

Insider Activity at AdaptHealth

In related news, insider Russell E. Schuster III sold 11,275 shares of the firm’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $10.06, for a total value of $113,426.50. Following the completion of the transaction, the insider directly owned 136,538 shares of the company’s stock, valued at approximately $1,373,572.28. This trade represents a 7.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Kenneth A. Samet bought 23,500 shares of the firm’s stock in a transaction that occurred on Thursday, August 6th. The stock was purchased at an average cost of $6.38 per share, with a total value of $149,930.00. Following the completion of the purchase, the director directly owned 48,569 shares of the company’s stock, valued at $309,870.22. This represents a 93.74% increase in their position. The SEC filing for this purchase provides additional information. Corporate insiders own 1.95% of the company’s stock.

Institutional Trading of AdaptHealth

Large investors have recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. grew its position in shares of AdaptHealth by 22.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock valued at $70,000 after acquiring an additional 1,279 shares during the period. MetLife Investment Management LLC raised its holdings in shares of AdaptHealth by 3.1% in the 4th quarter. MetLife Investment Management LLC now owns 57,364 shares of the company’s stock valued at $571,000 after purchasing an additional 1,749 shares during the period. Corient Private Wealth LLC raised its holdings in shares of AdaptHealth by 8.6% in the 4th quarter. Corient Private Wealth LLC now owns 22,562 shares of the company’s stock valued at $227,000 after purchasing an additional 1,794 shares during the period. Rockefeller Capital Management L.P. lifted its stake in AdaptHealth by 433.0% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock valued at $26,000 after purchasing an additional 2,100 shares during the last quarter. Finally, Assetmark Inc. lifted its stake in AdaptHealth by 54.8% in the 1st quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock valued at $83,000 after purchasing an additional 2,460 shares during the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Trading Up 4.5%

NASDAQ:AHCO opened at $5.63 on Wednesday. AdaptHealth has a twelve month low of $5.21 and a twelve month high of $13.43. The company has a quick ratio of 0.98, a current ratio of 1.12 and a debt-to-equity ratio of 1.37. The business has a 50 day moving average price of $9.12 and a two-hundred day moving average price of $10.24. The company has a market cap of $767.59 million, a P/E ratio of -3.29, a price-to-earnings-growth ratio of 0.27 and a beta of 1.47.

AdaptHealth (NASDAQ:AHCO) last posted its quarterly earnings data on Tuesday, August 4th. The company reported ($0.99) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($1.16). The business had revenue of $740.31 million during the quarter, compared to analyst estimates of $846.77 million. AdaptHealth had a negative net margin of 7.07% and a positive return on equity of 3.36%. AdaptHealth’s revenue for the quarter was down 7.5% on a year-over-year basis. During the same quarter last year, the business earned $0.10 earnings per share. As a group, analysts expect that AdaptHealth will post 0.44 EPS for the current fiscal year.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.